5 Things You Need to Know About the Drug Approval Process
This hand drawn white board video illustrates the 5 important stages of drug approval by the FDA. Discovery and Screening, IND Application Submission, Clinical Trials, Application Review and Inspections, and Safety Monitoring.
▶︎
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
▶︎
The Biosimilar Development Process
▶︎
193rd Vaccines and Related Biological Products Advisory Committee Meeting
▶︎
AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice
▶︎
Clinical Trial Basics
▶︎
FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers
▶︎
Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018
▶︎
How does the FDA approve new drugs?
▶︎
What Do You Need to Consider When Qualifying a Biomarker?
▶︎
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
▶︎
The Basics of Biosimilars
▶︎
Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019
▶︎
AGDD 2025 | D1S02 - Novel Bioequivalence Study Design Recommendations
▶︎
Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
▶︎
Biosimilars: Critical Quality Attributes
▶︎
Importing FDA-Regulated Products: Human Foods
▶︎
The Concept of Interchangeability
▶︎
Biomarker Terminology: Speaking the Same Language
▶︎
Biosimilars: Approval Process
▶︎